X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (63) 63
mice (60) 60
oncology (50) 50
humans (45) 45
female (39) 39
index medicus (26) 26
mice, transgenic (24) 24
mice, inbred balb c (22) 22
cell line, tumor (21) 21
expression (21) 21
cancer (19) 19
mice, nude (19) 19
male (18) 18
tumor cells, cultured (18) 18
tumors (18) 18
receptor, erbb-2 - genetics (17) 17
metastasis (16) 16
breast-cancer (15) 15
cells (15) 15
rhabdomyosarcoma (14) 14
disease models, animal (13) 13
mice, knockout (13) 13
transfection (13) 13
breast cancer (11) 11
immunoprevention (11) 11
rhabdomyosarcoma - pathology (11) 11
cancer vaccines - immunology (10) 10
gene expression regulation, neoplastic (10) 10
immunology (10) 10
lung neoplasms - secondary (10) 10
mammary neoplasms, experimental - immunology (10) 10
research (10) 10
rhabdomyosarcoma - metabolism (10) 10
carcinoma (9) 9
gene expression profiling (9) 9
receptor, erbb-2 - metabolism (9) 9
rhabdomyosarcoma - genetics (9) 9
sarcoma, ewing - metabolism (9) 9
transgenic mice (9) 9
vaccines (9) 9
xenograft model antitumor assays (9) 9
bone neoplasms - pathology (8) 8
cell biology (8) 8
mammary neoplasms, experimental - pathology (8) 8
mammary neoplasms, experimental - prevention & control (8) 8
medical research (8) 8
neoplasm metastasis (8) 8
prevention (8) 8
rats (8) 8
receptor, erbb-2 - immunology (8) 8
sarcoma, ewing - pathology (8) 8
antineoplastic agents - pharmacology (7) 7
antineoplastic agents - therapeutic use (7) 7
bone neoplasms - metabolism (7) 7
cancer vaccines (7) 7
carcinogenesis (7) 7
her-2 (7) 7
her-2/neu (7) 7
medicine (7) 7
neu (7) 7
osteosarcoma - metabolism (7) 7
pathology (7) 7
research article (7) 7
rodents (7) 7
sarcoma (7) 7
therapy (7) 7
time factors (7) 7
vaccination (7) 7
analysis (6) 6
angiogenesis (6) 6
animal models (6) 6
apoptosis (6) 6
bone neoplasms - drug therapy (6) 6
cancer vaccines - therapeutic use (6) 6
differentiation (6) 6
dose-response relationship, drug (6) 6
gene expression (6) 6
growth (6) 6
her2 (6) 6
in-vivo (6) 6
mammary carcinoma (6) 6
mammary neoplasms, experimental - genetics (6) 6
mice, inbred c57bl (6) 6
myogenic differentiation (6) 6
neoplasm transplantation (6) 6
osteosarcoma (6) 6
tumor (6) 6
vaccine (6) 6
adenocarcinoma - pathology (5) 5
antibodies (5) 5
antigen (5) 5
apoptosis - drug effects (5) 5
cell differentiation (5) 5
cell division (5) 5
chemotherapy (5) 5
disease progression (5) 5
down-regulation (5) 5
ewing's sarcoma (5) 5
her-2/neu transgenic mice (5) 5
immunohistochemistry (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Cancer, ISSN 1471-2407, 02/2019, Volume 19, Issue 1, pp. 126 - 7
BackgroundInsulin-like Growth Factor Receptor-1 (IGF1R) system sustains the genesis of rhabdomyosarcoma through IGF2 autocrine overexpression. While several... 
IGF2 | DNA vaccines | Neutralizing antibodies | Rhabdomyosarcoma | IGF1R | Immunoprevention | VACCINATION | MONOCLONAL-ANTIBODY | CANCER | INHIBITION | ONCOLOGY | BIOLOGY | MICE | SUPPRESSES | DIFFERENTIATION | PROGRESSION | VACCINES | Viral antibodies | Usage | Antibodies | Genetic aspects | Research | Insulin-like growth factor 1
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e39626
Journal Article
BMC Immunology, ISSN 1471-2172, 06/2018, Volume 19, Issue 1, pp. 16 - 16
Cancer immunoprevention is based on the fact that a functioning immune system controls tumor onset and development in humans and animals, thus leading to the... 
Cancer vaccines | Cancer immunoprevention | Oncoantigens | HER-2 | Genetically-modified mouse models | SAFETY | IFN-GAMMA | VACCINATION | PREVENTION | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | IMMUNOTHERAPY | INFECTION | PROTEINS | CARCINOMA | VACCINES | Prevention | Health aspects | Communicable diseases | Immune system | Tumors | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e83832
Metformin, a well-known insulin-sensitizer commonly used for type 2 diabetes therapy, has recently emerged as potentially very attractive drug also in... 
BREAST-CANCER | INSULIN-RECEPTOR ISOFORM | EWINGS-SARCOMA | INDUCIBLE FACTOR | IN-VITRO | MULTIDISCIPLINARY SCIENCES | GROWTH | METASTATIC ABILITY | HUMAN OSTEOSARCOMA CELLS | AMPK ACTIVATION | P-GLYCOPROTEIN | Osteosarcoma - drug therapy | Pediatrics | Vincristine - pharmacology | Apoptosis - drug effects | Humans | Rhabdomyosarcoma - metabolism | Sarcoma, Ewing - pathology | Rhabdomyosarcoma - pathology | Bone Neoplasms - pathology | Immunoenzyme Techniques | Bone Neoplasms - metabolism | Rhabdomyosarcoma - drug therapy | Bone Neoplasms - drug therapy | Tumor Cells, Cultured | Child | Real-Time Polymerase Chain Reaction | Osteosarcoma - metabolism | Sarcoma, Ewing - metabolism | Enzyme-Linked Immunosorbent Assay | Metformin - pharmacology | RNA, Messenger - genetics | Antineoplastic Combined Chemotherapy Protocols | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Hypoglycemic Agents - pharmacology | Sarcoma, Ewing - drug therapy | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Hypoxia - physiopathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Phytogenic - pharmacology | Osteosarcoma - pathology | Type 2 diabetes | Prevention | Chemotherapy | Sarcoma | Analysis | Metformin | Drug therapy | Health aspects | Diabetes therapy | Cancer | TOR protein | Laboratories | Pathogenesis | Rhabdomyosarcoma | Oncology | Insulin-like growth factors | Metastasis | Glucose | Kinases | Cancer therapies | Ewing's sarcoma | Biomedical materials | Cell growth | Osteosarcoma | Xenografts | Biocompatibility | Medical research | Diabetes mellitus | Breast cancer | Metabolism | Insulin | Fatty acids | Vincristine | Signaling | Bone cancer | Molecular modelling | Pancreatic cancer | Hypoxia | Solid tumors | Diabetes | Tumors
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 08/2019, Volume 9, Issue 1, pp. 12174 - 12
Standard therapy of osteosarcoma (OS) and Ewing sarcoma (EW) rests on cytotoxic regimes, which are largely unsuccessful in advanced patients. Preclinical... 
CELLS | APOPTOSIS | TUMOR XENOGRAFTS | PATHWAY | MULTIDISCIPLINARY SCIENCES | TISSUE | SENSITIVITY | GENERATION | CANCER | EWING SARCOMA | Caveolin-1 | Cell culture | Sarcoma | Caveolin | Cytotoxicity | Bone tumors | Leukocytes | Gene expression | Ewing's sarcoma | CD99 antigen | Irinotecan | Bone cancer | Chemotherapy | Molecular modelling | Osteosarcoma | Xenografts | P-Glycoprotein
Journal Article
Journal Article
PLoS Pathogens, ISSN 1553-7366, 01/2013, Volume 9, Issue 1, p. e1003155
Journal Article
CANCERS, ISSN 2072-6694, 04/2019, Volume 11, Issue 4, p. 517
(1) Background: Human epidermal growth factor receptor 2 (HER2)/neu-driven carcinogenesis is delayed by preventive vaccines able to elicit autochthonous... 
cancer vaccines | muscle neoplasms | IMMUNOPREVENTION | MAMMARY-CARCINOMA | DNA vaccines | MONOCLONAL-ANTIBODY | IGF1R | BREAST-CANCER | GROWTH-FACTOR RECEPTOR | DNA VACCINE | ONCOLOGY | HUMAN RHABDOMYOSARCOMA | MICE | HER2 | FACTOR-I RECEPTOR | EXPRESSION | neu | HER2/neu
Journal Article
BMC genomics, ISSN 1471-2164, 2014, Volume 15, Issue Suppl 3, pp. S1 - S1
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2014, Volume 14, Issue 1, pp. 137 - 137
Journal Article